Rafael Holdings Inc (RFL)
35.78
-0.18 -0.50%
NYSE
Feb 26, 20:00
USD
Rafael Holdings 52 Week Low (Daily)
View 4,000+ financial data types
Browse...
Historical 52 Week Low (Daily) Data
View and export this data going back to 2018.
Start your Free Trial
Export Data
Date Range:
Data for this Date Range | |
---|---|
Feb. 26, 2021 | Upgrade |
Feb. 25, 2021 | Upgrade |
Feb. 24, 2021 | Upgrade |
Feb. 23, 2021 | Upgrade |
Feb. 22, 2021 | Upgrade |
Feb. 19, 2021 | Upgrade |
Feb. 18, 2021 | Upgrade |
Feb. 17, 2021 | Upgrade |
Feb. 16, 2021 | Upgrade |
Feb. 12, 2021 | Upgrade |
Feb. 11, 2021 | Upgrade |
Feb. 10, 2021 | Upgrade |
Feb. 9, 2021 | Upgrade |
Feb. 8, 2021 | Upgrade |
Feb. 5, 2021 | Upgrade |
Feb. 4, 2021 | Upgrade |
Feb. 3, 2021 | Upgrade |
Feb. 2, 2021 | Upgrade |
Feb. 1, 2021 | Upgrade |
Jan. 29, 2021 | Upgrade |
Jan. 28, 2021 | Upgrade |
Jan. 27, 2021 | Upgrade |
Jan. 26, 2021 | Upgrade |
Jan. 25, 2021 | Upgrade |
Jan. 22, 2021 | Upgrade |
Jan. 21, 2021 | Upgrade |
Jan. 20, 2021 | Upgrade |
Jan. 19, 2021 | Upgrade |
Jan. 15, 2021 | Upgrade |
Jan. 14, 2021 | Upgrade |
Jan. 13, 2021 | Upgrade |
Jan. 12, 2021 | Upgrade |
Jan. 11, 2021 | Upgrade |
Jan. 8, 2021 | Upgrade |
Jan. 7, 2021 | Upgrade |
Jan. 6, 2021 | Upgrade |
Jan. 5, 2021 | Upgrade |
Jan. 4, 2021 | Upgrade |
Dec. 31, 2020 | Upgrade |
Dec. 30, 2020 | Upgrade |
Dec. 29, 2020 | Upgrade |
Dec. 28, 2020 | Upgrade |
Dec. 24, 2020 | Upgrade |
Dec. 23, 2020 | Upgrade |
Dec. 22, 2020 | Upgrade |
Dec. 21, 2020 | Upgrade |
Dec. 18, 2020 | Upgrade |
Dec. 17, 2020 | Upgrade |
Dec. 16, 2020 | Upgrade |
Dec. 15, 2020 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
View 52 Week Low (Daily) for RFL
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
Advertisement
52 Week High/Low Definition
The 52-Week High/Low is the highest and lowest price at which a security has traded during the previous 52 weeks.
52 Week Low (Daily) Benchmarks
Sunesis Pharmaceuticals Inc | Upgrade |
Salarius Pharmaceuticals Inc | Upgrade |
Constellation Pharmaceuticals Inc | Upgrade |
52 Week Low (Daily) Range, Past 5 Years
Minimum | Upgrade | Mar 27 2018 |
Maximum | Upgrade | Jan 14 2020 |
Average | Upgrade |
News
Sunesis Pharmaceuticals, Owens & Minor leads healthcare gainers; Rafael, Constellation Pharmaceuticals among major losers
SA Breaking News 02/24 10:59 ET
SA Breaking News 02/24 10:59 ET
LipoMedix Announces Manufacturing Agreement with ForDoz for Promitil®
Globe Newswire 02/10 09:00 ET
Globe Newswire 02/10 09:00 ET
Rafael Pharmaceuticals Secures Fast Track Status For CPI-613 in Acute Myeloid Leukemia
MT Newswires 12/15 11:18 ET
MT Newswires 12/15 11:18 ET
Rafael Pharma's devimistat fast track'd in U.S. for acute myeloid leukemia
SA Breaking News 12/15 10:41 ET
SA Breaking News 12/15 10:41 ET
What You Need To Know About Rafael Holdings, Inc.'s (NYSE:RFL) Investor Composition
Yahoo 12/01 04:01 ET
Yahoo 12/01 04:01 ET
Rafael Pharmaceuticals Gets Fast Track Designation for Pancreatic Cancer Treatment
MT Newswires 11/10 09:40 ET
MT Newswires 11/10 09:40 ET
Rafael Pharmaceuticals' Investigational Soft Tissue Cancer Drug Gets Orphan Drug Status from FDA
MT Newswires 10/29 10:05 ET
MT Newswires 10/29 10:05 ET
Miragen Therapeutics, Titan Pharmaceuticals leads healthcare gainers; Neovasc, Akerna among major losers
SA Breaking News 10/28 11:01 ET
SA Breaking News 10/28 11:01 ET
Rafael Pharmaceuticals Enrolls 100th Patient in Phase 3 Trial of CPI-613 for Treatment of Acute Myeloid Leukemia
MT Newswires 10/27 10:07 ET
MT Newswires 10/27 10:07 ET
Rafael Pharmaceuticals’ lead compound CPI-613 on go with early-stage study for pancreatic cancer
SA Breaking News 10/20 09:56 ET
SA Breaking News 10/20 09:56 ET
Advertisement